Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Methylprednisolone in COVID-19 ICU Patients
NCT04909918Phase 3Completed
- Sponsor
- Assiut University
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone, methylprednisolone injection in coronavirus disease 2019 (COVID-19), sponsored by Assiut University. Started May 2021; status: completed.
02
Drugs
dexamethasonemethylprednisolone injection
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04909918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04909918.